André Esanu

753 total citations
25 papers, 614 citations indexed

About

André Esanu is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Organic Chemistry. According to data from OpenAlex, André Esanu has authored 25 papers receiving a total of 614 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Cardiology and Cardiovascular Medicine and 5 papers in Organic Chemistry. Recurrent topics in André Esanu's work include Nitric Oxide and Endothelin Effects (4 papers), Neonatal Health and Biochemistry (3 papers) and Carbohydrate Chemistry and Synthesis (2 papers). André Esanu is often cited by papers focused on Nitric Oxide and Endothelin Effects (4 papers), Neonatal Health and Biochemistry (3 papers) and Carbohydrate Chemistry and Synthesis (2 papers). André Esanu collaborates with scholars based in France, Belgium and Hungary. André Esanu's co-authors include P. Braquet, M. Koltai, David Hosford, Philippe Guinot, Ricardo P. Garay, David D. Gilboe, Sherrie E. Emoto, Nicolás G. Bazán, Douglas B. Kintner and Corinne Nazaret and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of Neurochemistry and European Heart Journal.

In The Last Decade

André Esanu

24 papers receiving 584 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
André Esanu France 11 220 122 95 85 81 25 614
Enrique O’Connor Spain 11 238 1.1× 123 1.0× 92 1.0× 72 0.8× 60 0.7× 14 783
Kuo‐Hui Su Taiwan 19 404 1.8× 195 1.6× 95 1.0× 38 0.4× 48 0.6× 27 930
Iftekhar Alam United States 12 255 1.2× 154 1.3× 55 0.6× 58 0.7× 85 1.0× 19 740
Mona F. El-Azab Egypt 18 306 1.4× 62 0.5× 61 0.6× 43 0.5× 80 1.0× 37 790
Juntian Liu China 14 313 1.4× 68 0.6× 66 0.7× 34 0.4× 27 0.3× 31 786
Yinju Hao China 18 353 1.6× 75 0.6× 35 0.4× 124 1.5× 63 0.8× 41 779
Nagla A. El-Sherbeeny Egypt 14 151 0.7× 117 1.0× 101 1.1× 25 0.3× 57 0.7× 26 536
Laiyun Xin China 9 303 1.4× 54 0.4× 71 0.7× 81 1.0× 42 0.5× 12 647
Duen S. Chou Taiwan 9 156 0.7× 66 0.5× 73 0.8× 47 0.6× 16 0.2× 12 522
Sampath Parthasarathy United States 10 257 1.2× 161 1.3× 125 1.3× 34 0.4× 40 0.5× 12 1.1k

Countries citing papers authored by André Esanu

Since Specialization
Citations

This map shows the geographic impact of André Esanu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by André Esanu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites André Esanu more than expected).

Fields of papers citing papers by André Esanu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by André Esanu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by André Esanu. The network helps show where André Esanu may publish in the future.

Co-authorship network of co-authors of André Esanu

This figure shows the co-authorship network connecting the top 25 collaborators of André Esanu. A scholar is included among the top collaborators of André Esanu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with André Esanu. André Esanu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Szilvássy, Zoltán, et al.. (1993). Cicletanine attenuates overdrive pacing-induced global myocardial ischemia in rabbits. Coronary Artery Disease. 4(5). 443–452. 10 indexed citations
2.
Chabrier, Pierre‐Etienne, André Esanu, & P. Braquet. (1993). Vascular Remodeling and Antihypertensive Therapy. Journal of Cardiovascular Pharmacology. 21. S50–S53. 5 indexed citations
3.
Tomas, Α., et al.. (1993). An original linkage between arabinose and a pyranopyrimidine derivative via a sulfur atom. Acta Crystallographica Section C Crystal Structure Communications. 49(3). 626–628. 2 indexed citations
4.
Ferdinandy, Péter, M. Koltai, Árpád Tósaki, et al.. (1992). Cicletanine Improves Myocardial Function Deteriorated by Ischemia/Reperfusion in Isolated Working Rat Hearts. Journal of Cardiovascular Pharmacology. 19(2). 181–189. 10 indexed citations
5.
Garay, Ricardo P., et al.. (1992). Cicletanine sulfate: inhibition of anion transport systems and natriuretic activity. Naunyn-Schmiedeberg s Archives of Pharmacology. 346(1). 114–119. 6 indexed citations
6.
Bourgain, R.H., et al.. (1992). PAF-Acether Induced Arterial Thrombosis and the Effect of Specific Antagonists. Advances in experimental medicine and biology. 316. 427–440. 4 indexed citations
7.
Koltai, M., et al.. (1992). Effect of cicletanine on reperfusion-induced arrhythmias and myocardial ion contents: a comparison with furosemide. European Heart Journal. 13(3). 395–403. 7 indexed citations
8.
Braquet, P. & André Esanu. (1991). New trends in PAF antagonist research: A new series of potent hetrapazine-derived PAF antagonists. Inflammation Research. 32(1-2). 34–36. 12 indexed citations
9.
Gilboe, David D., Douglas B. Kintner, Sherrie E. Emoto, et al.. (1991). Recovery of Postischemic Brain Metabolism and Function Following Treatment with a Free Radical Scavenger and Platelet‐Activating Factor Antagonists. Journal of Neurochemistry. 56(1). 311–319. 69 indexed citations
10.
Braquet, P., et al.. (1991). Recent progress in ginkgolide research. Medicinal Research Reviews. 11(3). 295–355. 54 indexed citations
11.
Koltai, M., David Hosford, Philippe Guinot, André Esanu, & P. Braquet. (1991). PAF. Drugs. 42(2). 174–204. 108 indexed citations
12.
Braquet, P., J. Laurent, Alain Rolland, et al.. (1991). From ginkgolides to N-substituted piperidino-thieno diazepines, a new series of highly potent dual antagonists.. PubMed. 21B. 929–37. 10 indexed citations
13.
Koltai, M., David Hosford, Philippe Guinot, André Esanu, & P. Braquet. (1991). Platelet Activating Factor (PAF). Drugs. 42(1). 9–29. 171 indexed citations
14.
Garay, Ricardo P., et al.. (1991). Evidence for a suIfo-conjugate as active metabolite of cicletanine. Journal of Hypertension. 9. S344–S344. 1 indexed citations
15.
Marche, Patrice N., et al.. (1988). Histamine H1-receptors mediate phosphoinositide and calcium response in cultured smooth muscle cells-interaction with cicletanine (CIC). Inflammation Research. 24(3-4). 255–260. 6 indexed citations
16.
Braquet, P., et al.. (1986). Inhibition of the erythrocyte Na+, K+-pump by mammalian lignans. Pharmacological Research Communications. 18(3). 227–239. 13 indexed citations
17.
Braquet, P., et al.. (1986). Evidence that mammalian lignans show endogenous digitalis-like activities. Biochemical and Biophysical Research Communications. 134(3). 1064–1070. 28 indexed citations
18.
Braquet, P., et al.. (1986). Endogenous lignans--a potential endogenous digitalis.. PubMed. 4(5). S161–4. 10 indexed citations
19.
Leterrier, F, et al.. (1984). Isaxonine base is a strong perturber of phospholipid bilayer order and fluidity—A differential scanning calorimetry and spin labeling study. Biochemical Pharmacology. 33(15). 2407–2417. 3 indexed citations
20.
Pichat, L., et al.. (1982). Synthese du phosphate d'isopropylamino‐2 pyrimidine (14C2‐4,6) a tres forte activite specifique. Journal of Labelled Compounds and Radiopharmaceuticals. 19(2). 195–201.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Enrique O’Connor Breakdown of academic impact, for papers by Kuo‐Hui Su Breakdown of academic impact, for papers by Iftekhar Alam Breakdown of academic impact, for papers by Mona F. El-Azab Breakdown of academic impact, for papers by Juntian Liu Breakdown of academic impact, for papers by Yinju Hao Breakdown of academic impact, for papers by Nagla A. El-Sherbeeny Breakdown of academic impact, for papers by Laiyun Xin Breakdown of academic impact, for papers by Duen S. Chou Breakdown of academic impact, for papers by Sampath Parthasarathy
Rankless by CCL
2026